Back

Studies show that while high-growth startups attract investors, only about 1 in 10 venture-backed startups( India) achieve long-term success. Momentum alone isn't a moat—without profitability, strong unit economics, and adaptability, rapid growth oft

🚀Today we gonna talk about Mastering Metrics for Consumer Ventures 1. Growth Targets : - Aim for 15% month-over-month growth. - Prioritize organic growth with an 80:20 ratio. 2. Tracking Strategies: - Meticulously track user acquisiti

Exclusive Call: India’s Most Resilient Founders (Q1 2026) Profitability is no longer a "nice to have"—it’s the benchmark. Excess Edge Experts Consulting is now accepting applications for our Q1 Venture Pipeline. We are looking for a select group of S

𝗙𝗿𝗼𝗺 𝗕𝘂𝗿𝗻 𝘁𝗼 𝗘𝗮𝗿𝗻 A significant shift is underway in the Indian startup ecosystem. The era of unthinkingly chasing valuations through unchecked cash burn is coming to an end. Early stage entrepreneurs are rewriting the rules, prioritis

The ‘Unicorn’ Paradox: Why Funding Isn’t Always the Finish Line Everyone chases the unicorn. But what if achieving that $1B valuation isn’t the real finish line for a startup? Massive funding rounds can create the illusion of success—but behind the

💥 India’s Startup Reality Check: What No One Tells You (But Should) Think Indian startups only fail because of competition? Think again. From broken unit economics to brutal GST shocks—what really derails promising ventures? In our latest article,

The PAT Standard: Nominations Open for the Q1 2026 Venture Pipeline Profitability isn't a trend—it’s the new baseline for resilience. At Excess Edge Experts Consulting, we don’t just move capital; we amplify excellence. We are now scouting a select c

The 'Unicorn' Paradox: Why Funding Isn't Always the Finish Line Everyone chases the unicorn. But what if achieving that $1B valuation isn't the real finish line for a startup? The Financial Angle: Massive funding rounds can lead to hyper-growth, but

PharmEasy Turnaround in Focus as Docon Sells 10% Stake in Thyrocare for ₹668 Crore PharmEasy has been in the spotlight recently as it works toward stabilizing its business and improving margins after a challenging period of aggressive expansion and p

Startup Update: Otipy Shuts Down Operations Otipy, the once-popular farm-to-home grocery delivery platform, has officially shut down all operations. Customers have been informed via Call, with a promise that refunds will be processed within 60-90 da